- All sections
- A - Human necessities
- A61P - Specific therapeutic activity of chemical compounds or medicinal preparations
- A61P 31/04 - Antibacterial agents
Patent holdings for IPC class A61P 31/04
Total number of patents in this class: 14631
10-year publication summary
|
340
|
377
|
713
|
885
|
1005
|
1106
|
1111
|
1070
|
1291
|
953
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| King Faisal University | 921 |
232 |
| Glaxosmithkline Biologicals S.A. | 1650 |
112 |
| The Regents of the University of California | 20289 |
110 |
| Centre National de La Recherche Scientifique | 10693 |
102 |
| Pfizer Inc. | 3401 |
81 |
| Hoffmann-La Roche Inc. | 3533 |
65 |
| Intervet Inc. | 906 |
65 |
| iNtRON Biotechnology, Inc. | 178 |
61 |
| Intervet International B.V. | 1300 |
60 |
| Institut National de La Sante et de La Recherche Medicale (inserm) | 2991 |
55 |
| Merck Sharp & Dohme LLC | 3737 |
55 |
| Wockhardt Limited | 216 |
52 |
| Novartis AG | 10623 |
50 |
| Inserm (institut National de La Sante et de La Recherche Medicale) | 3373 |
50 |
| President and Fellows of Harvard College | 6036 |
47 |
| Bioversys AG | 74 |
44 |
| F. Hoffmann-La Roche AG | 7933 |
42 |
| Shionogi & Co., Ltd. | 835 |
41 |
| Rutgers, The State University of New Jersey | 1933 |
40 |
| Massachusetts Institute of Technology | 10143 |
38 |
| Other owners | 13229 |